Sebastian A. Meier-Ewert
Amministratore Delegato presso Prosalix GmbH
Posizioni attive di Sebastian A. Meier-Ewert
Società | Posizione | Inizio | Fine |
---|---|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Direttore operativo | 01/01/1997 | - |
Prosalix GmbH | Amministratore Delegato | 19/05/2011 | - |
Fondatore | 19/05/2011 | - |
Storia della carriera di Sebastian A. Meier-Ewert
Precedenti posizioni note di Sebastian A. Meier-Ewert
Società | Posizione | Inizio | Fine |
---|---|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Direttore Tecnico/Scientifico/R&S | 19/11/2009 | 02/12/2009 |
Fondatore | 19/11/2009 | 02/12/2009 | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Amministratore Delegato | 01/03/2016 | - |
Fondatore | 01/03/2016 | - | |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital operates as a entrepreneurial consulting and private equity company. It support companies during growth phases both through consulting regarding strategic and operational challenges as well as through investments. The company was founded in 2009 and is base in Muchen, Germany. | Amministratore Delegato | - | - |
SAW Instruments GmbH
SAW Instruments GmbH Medical SpecialtiesHealth Technology SAW Instruments GmbH designs, develops and sells biosensor-based laboratory instruments. Its products are used to measure proteins in cells, membranes and liposome's using an amplitude parameter to detect conformational changes. The firm carries out the orthodox functions of affinity measurements, kinetics and concentration determination. The company was founded by Sabine Bois and Markus Perpeet in 2010 and is headquartered in Munich, Germany. | Amministratore Delegato | 19/05/2011 | - |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Direttore/Membro del Consiglio | 19/11/2009 | - |
Formazione di Sebastian A. Meier-Ewert
University College London | Undergraduate Degree |
University of London | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 7 |
Regno Unito | 3 |
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 4 |
Founder | 3 |
Chief Operating Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Commercial Services |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
SAW Instruments GmbH
SAW Instruments GmbH Medical SpecialtiesHealth Technology SAW Instruments GmbH designs, develops and sells biosensor-based laboratory instruments. Its products are used to measure proteins in cells, membranes and liposome's using an amplitude parameter to detect conformational changes. The firm carries out the orthodox functions of affinity measurements, kinetics and concentration determination. The company was founded by Sabine Bois and Markus Perpeet in 2010 and is headquartered in Munich, Germany. | Health Technology |
Prosalix GmbH | |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital operates as a entrepreneurial consulting and private equity company. It support companies during growth phases both through consulting regarding strategic and operational challenges as well as through investments. The company was founded in 2009 and is base in Muchen, Germany. | Finance |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |